Skip to main content
UAB - The University of Alabama at Birmingham
admin login frontend login
Comprehensive Diabetes Center
Heersink School of Medicine
  • SOM Quicklinks
  • UAB Quicklinks
      • UAB Home
      • Academic Calendar
      • Accessibility
      • AdminSystems
      • Apply
      • AskIT
      • Blazer Express
      • BlazerNET
      • BlazerPulse
      • Bookstore
      • Campus Calendar
      • Campus Map
      • Canvas
      • Departments
      • Directory
      • Email
      • Emergency/B-Alert
      • Employee Resources
      • Employment
      • MyUAB Employee Portal
      • Giving to UAB
      • TechConnect
      • UAB eLearning
      More Items
 
  • Home
  • About
  • Faculty
  • Research
  • Patient Care
  • Giving
  • Contact Us
  • News & Updates

News & Updates


An oral medication shows benefits treating Type 1 diabetes for at least two years after diagnosis - News | UAB

Metformin use reduces risk of death for patients with COVID-19 and diabetes

Novel diabetes drug candidate shows promising properties in human islets and mouse models

Biomarker identified for early beta cell death in Type-1 diabetes 

Human clinical trial reveals verapamil as an effective Type 1 diabetes therapy

Targeting a microRNA shows potential to enhance effectiveness of diabetes drugs

Execs spark new diabetes initiative at UAB

 

 
  • Contact UAB
  • |
  • |
  • A-Z Site Index
  • |
  • Privacy
  • |
  • Terms of Use
  • |
  • © 2022 The University of Alabama at Birmingham
UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of race, national origin, age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.